Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole multicenter study in COVID-19 pneumonia
ChiCTR2000030055Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dipyridamole in coronavirus pneumonia (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Complete blood count, C-reactive protein and 4 more. Started Feb 2020; status: recruiting.
02
Drugs
dipyridamole
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000030055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030055.